LOS ANGELES CAPITAL MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 105 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,262,104
-18.9%
27,443
+1.3%
0.01%
-16.7%
Q2 2023$1,556,575
+56.8%
27,085
+2.3%
0.01%
+50.0%
Q1 2023$992,813
+254.3%
26,475
+164.8%
0.00%
+300.0%
Q4 2022$280,200
-15.1%
10,000
-14.9%
0.00%
-50.0%
Q3 2022$330,000
-19.3%
11,7550.0%0.00%0.0%
Q2 2022$409,000
+102.5%
11,755
+108.6%
0.00%
+100.0%
Q1 2022$202,000
-24.6%
5,635
-60.0%
0.00%
-50.0%
Q3 2016$268,000
+22.4%
14,105
+3.8%
0.00%0.0%
Q2 2016$219,000
+21.7%
13,585
-9.6%
0.00%0.0%
Q1 2016$180,00015,0350.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders